Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI101774

CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION: XXXII. THE COAGULATION DEFECT IN HEMOPHILIA. AN IN VITRO AND IN VIVO COMPARISON OF NORMAL AND HEMOPHILIC WHOLE BLOOD, PLASMA AND DERIVED PLASMA PROTEIN FRACTIONS

Jessica H. Lewis, C. S. Davidson, George R. Minot, J. P. Soulier, H. J. Tagnon, and F. H. L. Taylor

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Lewis, J. in: PubMed | Google Scholar

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Davidson, C. in: PubMed | Google Scholar

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Minot, G. in: PubMed | Google Scholar

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Soulier, J. in: PubMed | Google Scholar

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Tagnon, H. in: PubMed | Google Scholar

Thorndike Memorial Laboratory, Second and Fourth Medical Services, Boston City Hospital, Boston

Department of Medicine, Harvard Medical School, Boston

1

This paper is No. 44 in the “Studies of Plasma Proteins” of the Harvard Medical School, Boston, Massachusetts, on products developed by the Department of Physical Chemistry from blood collected by the American Red Cross.

Some of the products of plasma fractionation used in this work were developed from blood collected for the American Red Cross by the Department of Physical Chemistry, Harvard Medical School, under contract recommended by the Committee on Medical Research between the Office of Scientific Research and Development and Harvard University.

The expenses of this investigation were defrayed in part by a Gift to Harvard University from Smith, Kline and French Laboratories, of Philadelphia, and in part by a grant given “in recognition of Dr. Francis W. Peabody's services to the Foundation” by the Ella Sachs Plotz Foundation.

Find articles by Taylor, F. in: PubMed | Google Scholar

Published November 1, 1946 - More info

Published in Volume 25, Issue 6 on November 1, 1946
J Clin Invest. 1946;25(6):870–875. https://doi.org/10.1172/JCI101774.
© 1946 The American Society for Clinical Investigation
Published November 1, 1946 - Version history
View PDF
Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 870
page 870
icon of scanned page 871
page 871
icon of scanned page 872
page 872
icon of scanned page 873
page 873
icon of scanned page 874
page 874
icon of scanned page 875
page 875
Version history
  • Version 1 (November 1, 1946): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts